Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer’s Disease in Clinical Practice. This evidence concerns the gene SNCA and early-onset autosomal dominant Alzheimer disease.